Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know

Tilray Brands, Inc. (TLRY) ended the recent trading session at $9.02, demonstrating a -2.59% change from the preceding day's closing price. The stock fell short of the S&P 500, which registered a loss of 0.14% for the day. On the other hand, the Dow registered a loss of 0.2%, and the technology-centric Nasdaq decreased by 0.24%. Shares of the company have appreciated by 18.35% over the course of the past month, outperforming the Medical sector's loss of 0.56%, and the S&P 500's gain of 0.94%.Investors will be eagerly watching for the performance of Tilray Brands, Inc. in its upcoming earnings disclosure. The company's earnings report is set to be unveiled on January 8, 2026. In that report, analysts expect Tilray Brands, Inc. to post earnings of -$0.14 per share. This would mark year-over-year growth of 86%. Our most recent consensus estimate is calling for quarterly revenue of $209.65 million, down 0.62% from the year-ago period. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.25 per share and revenue of $866.74 million. These totals would mark changes of -350% and +5.53%, respectively, from last year. Investors should also note any recent changes to analyst estimates for Tilray Brands, Inc. Such recent modifications usually signify the changing landscape of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability. Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has shifted 44.44% upward. As of now, Tilray Brands, Inc. holds a Zacks Rank of #3 (Hold). The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 196, this industry ranks in the bottom 21% of all industries, numbering over 250. The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. You can find more information on all of these metrics, and much more, on Zacks.com. #1 Semiconductor Stock to Buy (Not NVDA)The incredible demand for data is fueling the market's next digital gold rush. As data centers continue to be built and constantly upgraded, the companies that provide the hardware for these behemoths will become the NVIDIAs of tomorrow.One under-the-radar chipmaker is uniquely positioned to take advantage of the next growth stage of this market. It specializes in semiconductor products that titans like NVIDIA don't build. It's just beginning to enter the spotlight, which is exactly where you want to be.See This Stock Now for Free >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Tilray Brands, Inc. (TLRY): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks